Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Arizona

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

California

Stanford University Medical Center
Palo Alto California 94304

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Sarcoma Oncology Research Center
Santa Monica California 90403

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Duarte California 91010

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

San Francisco California 94115

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Santa Monica California 90404

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Santa Monica California 90403

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Connecticut

UPDATED

New Haven Connecticut 06520

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

New Haven Connecticut

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

District of Columbia

MedStar Washington Hospital Center
Washington District of Columbia 20010

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Florida

Mayo Clinic of Jacksonville
Jacksonville Florida 32224

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Jacksonville Florida 32224

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Miami Florida 33136

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Miami Florida 33136

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

UPDATED

Tampa Florida 33612

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

Georgia

Georgia Cancer Specialists
Sandy Springs Georgia 30342

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Atlanta Georgia 30342

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Illinois

Northwestern University Feinburg School of Medicine
Chicago Illinois 60611

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Iowa

University of Iowa Hospital and Clinics
Iowa City Iowa 52242

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Radiotherapy for the treatment of Soft Tissue Sarcoma

Kansas

UPDATED

Overland Park Kansas 66210

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

Maryland

Baltimore Maryland 21287

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Baltimore Maryland 21218

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Boston Massachusetts 02215

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

UPDATED

Detroit Michigan 48201

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Missouri

Washington University in St. Louis
St. Louis Missouri 63110

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

St. Louis Missouri 63110

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Nebraska

Omaha Nebraska 68114

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York

Tisch Cancer Institute
New York New York 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Buffalo New York 92122

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Lake Success New York 11042

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10065

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10032

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York New York 10032

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

New York New York 10032

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

North Carolina

Levine Cancer Institute
Charlotte North Carolina 28204

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Duke Cancer Institute
Durham North Carolina 27710

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Durham North Carolina 27710

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma